Charles River Laboratories (CRL) Tops Q4 EPS by 23c; Guides FY23 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $326.29 --0%
Financial Fact:
Income from continuing operations, net of tax: 37.69M
Today's EPS Names:
ROX, KEEL, SENEA, More
Financial Fact:
Income from continuing operations, net of tax: 37.69M
Today's EPS Names:
ROX, KEEL, SENEA, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $2.98, $0.23 better than the analyst estimate of $2.75. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Charles River Laboratories sees FY2023 EPS of $9.70-$10.90. Charles River Laboratories sees FY2023 revenue of $11.37 billion. Revenue growth, reported up 1.5-4.5%. Sees Revenue growth, organic up 4.5-7.5%.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parker-Hannifin (PH) Tops Q1 EPS by 69c ; Offers Guidance
- Enovis Corporation (ENOV) Tops Q3 EPS by 11c ; Offers Guidance
- Appian Corporation (APPN) Tops Q3 EPS by 18c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
